MTRI MENTARI THERAPEUTICS INC
FollowCommon Stock, par value $0.0001 per share (common), issuer CIK 1728328
No 13F filer reports this security in the loaded quarters.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Fairmount Funds Management LLC(group Fairmount Funds Management LLC)
10,555,507 shares, 19.99% in a 13D as of 2026-11-06,0001193125-26-458677
Accepted , ingested - Commodore Capital LP(group Commodore Capital LP)
2,977,630 shares, 5.6% in a 13G as of 2026-11-06,0001831942-26-000046
Accepted , ingested - Deep Track Capital, LP(group Deep Track Capital, LP)
2,977,478 shares, 5.64% in a 13G as of 2026-11-06,0001172661-26-005030
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
Events
Commodore Capital LP and 3 other reporting persons reported 2,977,630 MTRI shares, 5.6% of the class, as of 2026-11-06, in a 13G filed 2026-11-13. 0001831942-26-000046
Accepted , ingestedDeep Track Capital, LP and 3 other reporting persons reported 2,977,478 MTRI shares, 5.64% of the class, as of 2026-11-06, in a 13G filed 2026-11-13. 0001172661-26-005030
Accepted , ingestedFairmount Funds Management LLC and 3 other reporting persons reported 10,555,507 MTRI shares, 19.99% of the class, as of 2026-11-06, in a 13D filed 2026-11-12. 0001193125-26-458677
Accepted , ingested